Our participation in the Global HPV Screening Proficiency Study – 2024 resulted in full approval of our HPV Genotyping Test, meeting all established criteria.
This international study, coordinated by the World Health Organization’s HPV LabNet (HPV Laboratory Network), aims to ensure the quality and comparability of HPV detection and genotyping methods worldwide. Laboratories across the globe are challenged to accurately identify the various HPV types present in coded samples using their routine methodologies.
Our participation in this study reinforces IMP Diagnostics’ ongoing commitment to delivering high-quality, accurate diagnostic solutions. This international recognition not only validates the effectiveness of our tests but also highlights our dedication to upholding the highest standards of quality and innovation in HPV diagnostics.
You May Like: Data on Sexually Transmitted Infections and the Impact of IMP Diagnostics’ STI Panel